CURE Inaugural Commercial to Air During SU2C Telecast

Article

CURE Media Group, the nation’s leading digital and print media enterprise dedicated to patients and survivors of cancer, will launch its first television commercial featuring curetoday.com during the Stand Up To Cancer (SU2C) telecast tonight.

CURE Media Group, the nation’s leading digital and print media enterprise dedicated to patients and survivors of cancer, will launch its first television commercial featuring curetoday.com during the Stand Up To Cancer (SU2C) telecast tonight, announced Michael J. Hennessy Jr., president of MJH Associates, Inc., parent company of CURE Media Group. The commercial aims to give individuals with cancer a platform to voice how they are more than just patients.

“We are so honored to be recognized during the Stand Up To Cancer (SU2C) telecast,” said Michael J. Hennessy Jr., in making the announcement. “This is a huge achievement for the CURE Media Group and we are so thankful to get our message across airing our first commercial.”

CURE® message, “Today, I’m more than a patient,” will fill millions of screens during SU2C’s sixth biennial televised fundraising special. CURE® hopes viewers will share how they are more than a patient, using the hashtag #MoreThanAPatient on social media.

The commercial will air on CBS in New York, San Francisco and Boston on Friday, Sept. 7 at 8 p.m. ET/PT and 7 p.m. CT.

To see the commercial after it airs, visit http://www.curetoday.com or find us on Twitter @cure_magazine, Facebook @curemagazine or Instagram @curetoday.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey. If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key. “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained. READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content
Image of the FDA's logo on a light blue background.

FDA Grants Fast Track Designation to CTX-009 in Biliary Tract Cancer

April 26th 2024
Article

The combination of bispecific antibody CTX-009 and chemotherapy received Fast Track Designation for advanced, previously treated biliary tract cancers.

Read More

cancer horizons logo: a white microphone on a navy blue background

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

March 11th 2024
Podcast

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

Listen

Image of an X-ray showing the pancreas.

Meg Bennett Died, ‘Star Trek’ Actress Still Cancer-Free After 20 Years and More

April 26th 2024
Article

From “The Young and the Restless” actress dying of cancer to “Star Trek” actress 20 years pancreatic cancer-free, here’s what’s happening in the cancer space this week.

Read More

cancer horizons podcast logo: a white microphone on a blue background

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

March 4th 2024
Podcast

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.

Listen

Image of red blood cells.

Early Transfusions, Treatments May Improve Outcomes in Low-Risk MDS

April 25th 2024
Article

Receiving early transfusions and treatment to reduce transfusion dependency significantly improves survival and quality of life in low-risk MDS.

Read More

Illustration of a man with longer gray hair.

The Long and Winding Road Leading to My Non-Hodgkin Lymphoma

April 25th 2024
Article

The day I found out I had cancer, my wife and I thought I would just be going in for a scan.

Read More